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Abstract
Background: The chemopreventive effect of green tea polyphenols, such as (-)-epigallocatechin-3-gallate (EGCG), has been
well demonstrated in cell culture studies. However, a wide range of IC50 concentrations has been observed in published
studies of the anti-proliferative activity of EGCG from different laboratories. Although the susceptibility to EGCG treatment is
largely dependent on cancer cell type, the particular cell viability and proliferation assays utilized may significantly influence
quantitative results reported in the literature.
Methodology/Principal Findings: We compared five widely used methods to measure cell proliferation and viability after
EGCG treatment using LNCaP prostate cancer cells and MCF-7 breast cancer cells. Both methods using dyes to quantify
adenosine triphosphate (ATP) and deoxynucleic acid (DNA) showed accuracy in the measurement of viable cells when
compared to trypan blue assay and results showed good linear correlation (r=0.95). However, the use of MTT (3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium) as indicators of metabolically active mitochondria overestimated the number of viable
cells by comparison with the ATP, DNA, or trypan blue determinations. As a result, the observed IC50 concentration of EGCG
was 2-fold higher using MTT and MTS compared to dyes quantifying ATP and DNA. In contrast, when cells were treated with
apigenin MTT and MTS assays showed consistent results with ATP, DNA, or trypan blue assays.
Conclusions/Significance: These results demonstrate that MTT and MTS -based assays will provide an underestimation of
the anti-proliferative effect of EGCG, and suggest the importance of careful evaluation of the method for in vitro assessment
of cell viability and proliferation depending on the chemical nature of botanical supplements.
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Introduction
Tea and tea polyphenols are promising chemopreventive agents
against a variety of tumors, including lung, esophagus, stomach,
liver, prostate, pancreas, colon, and breast [1–5]. The active
constituents in green tea are believed to be polyphenols including
(-)-epigallocatechin, (-)-epigallocatechin-3-gallate (EGCG), (-)-epi-
catechin, and (-)-epicatechin-3-gallate, with EGCG being the most
abundant and possibly the most bioactive of the green tea
polyphenols [6].
In vitro cell culture studies are valuable tools for screening of
chemopreventive agents and provide preliminary data for in vivo
studies. The anti-proliferative activity of EGCG has been
demonstrated in various cancer cell lines, however, the half
maximal inhibitory concentration (IC50) values from different
studies vary greatly from tens to hundreds of mmol/L of EGCG
[7-9]. The susceptibility to EGCG treatment is largely dependent
on cell type. However the choice of method to evaluate viability
and proliferation may also significantly influence the quantitative
assessment of anti-proliferative activities of botanicals such as
green tea.
Many methods have been developed to measure cell prolifer-
ation including those based on direct counting of viable cells,
measurement of metabolic activity and cellular DNA content. The
traditional cell counting methods such as trypan blue dye exclusion
assay using a hemacytometer are simple and inexpensive but very
time consuming and sometimes inaccurate [10]. Measurement of
mitochondrial metabolic rate using MTT (3-(4,5-Dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide) and MTS (3-(4,5-di-
methylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium) to indirectly reflect viable cell numbers has been
widely applied [7-9,11]. However, metabolic activity may be
changed by different conditions or chemical treatments which can
cause considerable variation in results reported from these assays
[12,13].
In the present study, we compared the results of the methods
using trypan blue, MTT, MTS, as well as dyes quantifying ATP
and DNA to determine the effect of EGCG and apigenin on cell
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MCF-7 breast cancer cells.
Materials and Methods
Chemicals and Reagents
EGCG (.95% purity), MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide), and dimethyl sulfoxide (DMSO)
were purchased from Sigma Chemicals (St Louis, MO). CellTiter
96H AQueous One Solution Cell Proliferation Assay (MTS) kit and
CellTiter-GloH Luminescent Cell Viability Assay (ATP) kit were
purchased from Promega Corporation (Madison, WI). Cy-
QUANTH NF Cell Proliferation Assay (DNA) Kit was purchased
from Invitrogen Corporation (Carlsbad, CA).
Cell Line and Cell Culture
The human prostate adenocarcinoma LNCaP cells was
obtained from ATCC (Chicago, IL), and cultured in RPMI
1640 medium with glutamine supplemented with 10% (v:v) of fetal
bovine serum (FBS) (USA Scientific, Ocala, FL), 100 IU/ml of
penicillin and 100 mg/ml of streptomycin (Invitrogen Inc,
Carlsbad, CA). The MCF-7 cells were generously provided by
the Chen Lab, City of Hope/Beckman Research Institute (Duarte,
CA). The cells were transfected with aromatase gene [14]. The
cells were cultured in MEM medium with glutamine containing
10% FBS, 1 mM sodium pyruvate, 10 IU/ml of penicillin and
10 mg/ml of streptomycin, and 100 mg/ml of G418. All the cells
were cultured at 37 mC in a 5% CO2 incubator. At pH above 6.5
EGCG undergoes autoxidation and dimerization and forms
hydrogen peroxide (H2O2) [15]. To minimize the H2O2 effect
50 units/ml of catalase was added to the medium prior to EGCG.
In addition, another flavonoid apigenin was used as a control
compound to validate the interference of EGCG with different
assays. LNCaP cells (1610
4 per well on 96-well plate) were treated
with either DMSO, 15 mmol/L or 30 mmol/L apigenin for 24 h,
48 h, or 72 h, and the viable cells were measured with the same
assays as that for EGCG treated cells.
Trypan Blue Exclusion Assay
LNCaP cells were seeded into 96-well plates at a density of
1610
4 per well (100 ml) and treated with the following: vehicle
control (DMSO), EGCG at 40 and 80 mmol/L. MCF-7 cells were
seeded into 96-well plates at a density of 0.8610
4 per well and
treated with the following: vehicle control (DMSO), EGCG at 20
and 40 mmol/L. The cells were treated for 24 h, 48 h, or 72 h,
and cell growth was photographed under microscope at each time
point.
Cell viability was determined by trypan blue dye exclusion
assay. Triplicate wells of viable cells for each concentration were
counted on a hemacytometer after trypsinization. Each well had
three repeats of counting. The experiment was repeated three
times.
MTT and MTS Assays
LNCaP cells were seeded into 96-well plates at a density of
1610
4 per well (100 ml) and treated with the following: vehicle
control (DMSO), EGCG at 40 and 80 mmol/L. MCF-7 cells were
seeded into 96-well plates at a density of 0.8610
4 per well and
treated with the following: vehicle control (DMSO), EGCG at 20
and 40 mmol/L. Wells with serum free medium were used as
negative control. The cells were treated for 24 h, 48 h, or 72 h.
For the MTT assay, at 3 h before each of the desired time
points, 20 ml of MTT solution (5 mg/ml in PBS) was added into
each well and cells were incubated at 37 mC for another 3 h. The
medium was removed and 100 ml of DMSO was added into each
well. The plate was gently rotated on an orbital shaker for 10 min
to completely dissolve the precipitation. The absorbance was
detected at 570 nm with a Microplate Reader (VersaMax,
Molecular Devices, Sunnyvale, CA).
For the MTS assay, the CellTiter 96H AQueous One Solution
Cell Proliferation Assay kit was used following the manufacturer’s
instruction. Briefly, at 3 h before each of the desired time points,
10 ml of the MTS reagent was added into each well and cells were
incubated at 37 mC for 3 h. The absorbance was detected at
490 nm with a Microplate Reader (VersaMAx, Molecular
Devices). All the experiment was repeated three times.
ATP and DNA Assays
LNCaP cells were seeded into 96-well opaque-walled plates at a
density of 1610
4 per well (100 ml) and treated with the following:
vehicle control (DMSO), EGCG at 10, 20, 40, 60, 80, 100, and
120 mmol/L; MCF-7 cells were seeded into 96-well plates at a
density of 0.8610
4 per well and treated with the following: vehicle
control (DMSO), EGCG at 10, 20, 30, 40, 60, and 80 mmol/L for
24 h, 48 h, or 72 h. Wells with serum free medium were used as
negative control.
The CellTiter-GloH Luminescent Cell Viability Assay kit was
used for ATP assay following the manufacturer’s instruction.
Briefly, the assay buffer and substrate were equilibrated to room
temperature, and the buffer was transferred to and gently mixed
with the substrate to obtain a homogeneous solution. After a
30 min equilibration of the cell plate to room temperature, 100 ml
of the assay reagent was added into each well and the content was
mixed for 2 min on an orbital shaker to induce cell lysis. After
10 min incubation in room temperature, the luminescence was
read on a Microplate Reader (SpectraMax GeminiEM, Molecular
Devices, Sunnyvale, CA).
The CyQUANTH NF Cell Proliferation Assay kit was used for
DNA assay following the manufacturer’s instruction. Briefly, the
cell growth medium was removed and 100 ml of 1x lysis/dye
binding solution was added into each well. The plate was
incubated at 37 mC for 50 min, and the fluorescence intensity
was measured on a Microplate Reader (SpectraMax GEminiEM,
Molecular Devices) with a wavelength of 485 nm for excitation
and 530 nm for emission. All the experiments were repeated three
times.
Statistical Analysis
SPSS (Version 18.0, Chicago, IL) was used for all statistical
analyses. Mean value and standard deviation were calculated using
descriptive statistics. IC50 values were calculated by Probit
regression. Comparison of means was performed by one-way
analysis of variance with Tukey’s posttest. Comparison of assays
was made by correlation and linear regression analysis. Differences
were considered significant if P,0.05.
Figure 1. Proliferation of LNCaP cells and MCF-7 cells treated with EGCG. A: LNCaP cells were seeded into 96-well plates at a density of
1610
4 per well and treated with the following: vehicle control (NT), EGCG at 40 and 80 mmol/L. B: MCF-7 cells were seeded at a density of 8610
3 per
well and treated with the following: vehicle control (NT), EGCG at 20 and 40 mmol/L. Pictures were taken by microscope at 24 h (A), 48 h (B), and 72 h
(C).
doi:10.1371/journal.pone.0010202.g001
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PLoS ONE | www.plosone.org 3 April 2010 | Volume 5 | Issue 4 | e10202Figure 2. Trypan blue assay was used to determine cell proliferation after EGCG treatment. A: LNCaP cells; B: MCF-7 cells. The superscript
letters represent significant difference between groups (P,0.05):
a compared to vehicle control;
b compared to the 24 h value. Error bars represent
standard deviation.
doi:10.1371/journal.pone.0010202.g002
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represent significant difference between groups (P,0.05):
a compared to vehicle control;
b compared to the 24 h value. Error bars represent standard
deviation.
doi:10.1371/journal.pone.0010202.g003
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significant difference between groups (P,0.05):
a compared to vehicle control;
b compared to the 24 h value. Error bars represent standard deviation.
doi:10.1371/journal.pone.0010202.g004
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PLoS ONE | www.plosone.org 6 April 2010 | Volume 5 | Issue 4 | e10202Figure 5. MTT assay was used to determine viability of cells treated with EGCG. A: LNCaP cells; B: MCF-7 cells. The superscript letters
represent significant difference between groups (P,0.05):
a compared to vehicle control;
b compared to the 24 h value. Error bars represent standard
deviation.
doi:10.1371/journal.pone.0010202.g005
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PLoS ONE | www.plosone.org 7 April 2010 | Volume 5 | Issue 4 | e10202Figure 6. MTS assay was used to determine viability of cells treated with EGCG. A: LNCaP cells; B: MCF-7 cells. The superscript letters
represent significant difference between groups (P,0.05):
a compared to vehicle control;
b compared to the 24 h value. Error bars represent standard
deviation.
doi:10.1371/journal.pone.0010202.g006
MTT and MTS Assay Limitations
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This study has demonstrated a twofold underestimation of the
anti-proliferative effect of EGCG when using MTT or MTS,
suggesting that these dyes give results different from direct
measures of ATP or DNA or direct counting of viable cells to
determine the antiproliferative effect of green tea polyphenols or
other phytochemicals. It is possible that polyphenols may interfere
with formazan formation critical to the MTT or MTS methods.
Outcomes of the experiments using the methods quantifying ATP
and DNA were highly correlated and both of them were consistent
with the trypan blue assay.
As shown in Figures 1 and 2, EGCG treatment inhibited the
proliferation of both LNCaP cells and MCF-7 cells in a dose-
dependent manner. Both ATP and DNA assays detected a
significant inhibition of LNCaP cell proliferation by 30%
compared to the control when cells were treated with 40 mMo f
EGCG for 72 h (P,0.05) (Figure 3A & 4A); However, using the
MTT or MTS methods viability was increased by 15% compared
to the control (P,0.05) (Figure 5A & 6A). When LNCaP cells were
treated with 80 mM of EGCG for 72 h, cell proliferation was
inhibited by 65% using the ATP or DNA methods relative to the
control while viability was only inhibited by 30% using the MTT
or MTS methods.
Similar results were obtained with MCF-7 cells. A significant
inhibition of cell proliferation by 20% was detected using ATP or
DNA methods when MCF-7 cells were treated with EGCG at
20 mM for 72 h (Figure 3B & 4B), compared to a 5% increase of
viable cell count observed when using MTT or MTS assays
(Figure 5B & 6B). When cells were treated with 40 mM of EGCG
for 72 h, the inhibition of cell proliferation was around 70% using
the ATP or DNA assays relative to the control compared to less
than 40% when the MTT or MTS assays were used.
The results derived by using the ATP and DNA methods
demonstrated a significant linear relationship (r=0.95) and IC50
values obtained from the ATP and DNA assays were similar:
55 mM of EGCG for LNCaP and 35 mM EGCG for MCF-7 cells
at 72 h. However, the IC50 values obtained from the MTT or
MTS assays were much higher (120 mM of EGCG for LNCaP and
60 mM EGCG for MCF-7 cells at 72 h) when compared to the
ATP and DNA methods.
In contrast, when LNCaP cells were treated with apigenin both
MTT and MTS assays showed accuracy in measurement of cell
growth as demonstrated by a high consistence of the outcome from
MTT or MTS assay with that from ATP, DNA, or trypan blue
assays (r=0.96) (Table 1).
Discussion
The present study demonstrated a significant difference in the
determination of the antiproliferative activity of EGCG when
using the MTT or MTS-based assays by comparison to ATP and
DNA-based methods and trypan blue assay. MTT is a tetrazolium
salt that is reduced to purple formazan crystals mainly by
mitochondrial succinate dehydrogenase [16]. The MTS is an
alternative to MTT and the formazan formed from MTS is water-
soluble and less toxic [17]. Theoretically, the color intensity of the
formazan dye is correlated to the number of viable cells. However,
some chemicals or phytochemicals may change the activity of
succinate dehydrogenase or interact with MTT directly [13,18]. In
the present study, the MTT and MTS methods did not show an
antiproliferative activity using 40 mM of EGCG treatment, and
was less sensitive at 80 mM EGCG treatment compared to the
ATP- and DNA-based methods. EGCG has been shown to protect
against mitochondria injury and greatly increase the activity of
succinate dehydrogenase [13,18]. This may enable the injured
cells to reduce MTT or MTS and increase the production of
formazan by the same number of cells. In addition, Bruggisser et
al. [19] and Wisman et al. [20] found a direct reduction of MTT
to formazan by some phenolics including kaempferol and EGCG
in the absence of cells, and washing the cells before adding MTT
reduced the interference [19]. However, for those cells of less
adherence such as LNCaP cells, the washing process may cause
loss of cells.
The ATP-based method is highly sensitive, reproducible and
simple for the evaluation of cell viability and proliferation [21,22].
It is based on the quantitation of cellular ATP using the luciferin-
luciferase reaction to produce bioluminescence [23]. ATP
degrades rapidly in dead cells and declines in injured cells.
Therefore, the amount of ATP present in the cells is proportional
to the number of viable cells in culture [23]. In the present study,
using the ATP-based assay a dose-dependent decrease of viable
cell numbers of both LNCaP and MCF-7 cells was observed, and a
statistically significant decrease was observed at 40 mM of EGCG
treatment of LNCaP cells and 20 mM of EGCG treatment of
MCF-7 cells. These results are consistent with the number of cells
observed in the microscopic pictures of cell culture plates and the
direct cell counting from trypan blue exclusion assay. Similar
results were obtained using the DNA-based method, which is
based on the measurement of cellular DNA to indicate the relative
cell number since cellular DNA content is highly regulated [24]. In
the DNA-based assay kit used, the fluorescent dye binds to cellular
nucleic acid and exhibits strong fluorescence with an excitation
Table 1. Comparison of different assays to determine the effect of apigenin on LNCaP cell proliferation.
24 h 48 h 72 h
Assays Low dose* High dose Low dose High dose Low dose High dose
Trypan blue 84.666.7 53.867.0
a 65.764.1
ab 16.362.2
ab 58.263.9
ab 13.463.9
ab
ATP 84.965.8 55.667.0
a 68.863.3
ab 19.762.5
ab 60.365.8
ab 16.461.9
ab
DNA 83.668.9 63.666.5
a 67.462.1
ab 22.460.9
ab 59.369.2
ab 9.760.9
ab
MTT 81.663.5
a 58.662.1
a 68.263.5
ab 21.762.6
ab 64.267.0
ab 21.762.6
ab
MTS 85.664.2
a 50.362.2
a 68.665.0
ab 19.861.5
ab 64.266.0
ab 16.461.5
ab
* LNCaP cells were treated with apigenin at concentrations of 0 (DMSO), 15 mM (low dose), or 30 mM (high dose), and cell growth were assayed at desired time points.
Values represent the percentage of viable cells compared to the vehicle (DMSO) control group and are presented in mean 6 standard deviation.
acompared to vehicle control, P,0.05;
bcompared to the 24 h value, P,0.05.
doi:10.1371/journal.pone.0010202.t001
MTT and MTS Assay Limitations
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able to detect a linear range from less than 100 to 100,000 cells/
well [21,24]. The values from these two assays showed a significant
correlation in the present study. However, using the DNA-based
method the medium has to be removed before adding the reagent,
which may cause loss of cells that are not well attached to the
culture plate.
Regarding the possibility of the interference caused by cell
density, we seeded LNCaP cells at different densities: 3610
3 per
well and 6610
3 per well on 96-well plates, however, a similar
outcome was observed compared to seeding cells at 1610
4 per well
using the five assays (data not shown). In addition, we examined
the possible interferences of different cell types with the assays
using another flavonoid apigenin as a control compound.
Eventually all the assays performed well to assess the inhibition
of cell proliferation by apigenin treatment, which further supports
that the interference with MTT and MTS assays was caused by
EGCG.
In summary, MTT and MTS-based methods resulted in an
underestimation of the anti-proliferative effects of EGCG probably
due to the increased activity of mitochondrial dehydrogenase in
response to EGCG treatment and the intrinsic potential of EGCG
to reduce MTT and MTS and increase the formation of
formazan. The ATP- and DNA-based methods were highly
correlated and both demonstrated antiproliferative activity of
EGCG consistently. These results demonstrate the need for careful
evaluation of the methods used for the in vitro evaluation of cell
proliferation depending on the chemical nature of botanical
supplements to be evaluated.
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